Melissa Lynne Johnson
Melissa Lynne Johnson publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Research Studies.
- World rank
- #30,657 of 7,710,434 ranked researchers
- Rank in United States
- #11,608 of 1,627,098
- Works
- 868
- Citations
- 26k
- Citations per work
- 29.6
What does Melissa Lynne Johnson research?
Melissa Lynne Johnson's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences57966.7%
- Medicine57966.7%
- Life Sciences17219.8%
- Everything else11713.5%
- 1Oncology40% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Molecular Biology11% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Immunology5% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe Melissa Lynne Johnson's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, Immunotherapy, ALK Inhibitors, EGFR Mutations, Immune Checkpoint Blockade and PD-1 and PD-L1.
- Dendritic Cells
- Cancer Genomics
- Cetuximab
- CT Screening
- CAR T Cells
- Small-Cell Lung Cancer
- PD-1 and PD-L1
- EGFR Mutations
- Immunotherapy
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- ALK Inhibitors
- Immune Checkpoint Blockade
- Genomic Profiles
- Cancer Immunotherapy
- Chimeric Antigen Receptor
- Lung Cancer
- KRAS Mutations
- Mutational Signatures
- Immunity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Targeted Therapy3923 topics
- Clinical Trials3422 topics
- Chemotherapy2443 topics
- Immunotherapy2162 topics
- ALK Inhibitors2061 topic
- EGFR Mutations2061 topic
- Immune Checkpoint Blockade1671 topic
- PD-1 and PD-L11671 topic
- Genomic Profiles1361 topic
- Small-Cell Lung Cancer1361 topic
- Cancer Immunotherapy1282 topics
- CAR T Cells801 topic
- Chimeric Antigen Receptor801 topic
- CT Screening561 topic
- Lung Cancer561 topic
- Cetuximab521 topic
- KRAS Mutations521 topic
- Cancer Genomics501 topic
- Mutational Signatures501 topic
- Dendritic Cells481 topic
- Immunity481 topic
Where does Melissa Lynne Johnson work?
Melissa Lynne Johnson's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Melissa Lynne Johnson have?
OpenAlex counts 868 works and 25,700 citations for Melissa Lynne Johnson, an h-index of 68, ranking #30,657 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Melissa Lynne Johnson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.